Search Results for "Butal Acet Caff 50 325 40mg"

22:41 EDT 4th July 2015 | BioPortfolio

Matching Channels

None

Matching News

FDA approves Cipla’s Lopinavir/ritonavir for AIDS in infants and young children

Cipla, a global pharmaceutical company, has received FDA approval for Lopinavir/ritonavir (LPV/r) 40mg/10mg oral pellets for paediatric specific treatment for infants.

Fitch: SCOTUS Extends Patent Benefit for Teva; Generics Lose for Now

A Supreme Court (SCOTUS) decision that a federals appeals court wrongly overturned Teva Pharmaceutical's (Teva) Copaxone patent is a positive credit development for the drug maker...

Osteo Bi-Flex® Introduces EASE Mini-Tabs: Collagen-Based Formula For Every Day Joint Comfort

NEW YORK, May 20, 2015 /PRNewswire/ -- Joint health supplement market leader Osteo Bi-Flex® today introduced Osteo Bi-Flex® EASE, a daily mini-tab that promotes joint comfort through a ...

DelMar Pharmaceuticals Presents Updated Clinical Data on Phase I/II Study of VAL-083 in Refractory Glioblastoma Multiforme (GBM)

VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on deve...

Neurocrine Biosciences Reports Year-End 2014 Results and Provides Investor Update for 2015

SAN DIEGO, Feb. 9, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter and year ended December 31, 2014. For the fourth quarter...

Neurocrine Biosciences Reports First Quarter 2015 Results

SAN DIEGO, April 30, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2015. For the first quarter of 2015, the...

DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015

VANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 12, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar", "the Company) provided an update on the Company's ongoing P...

Teva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection in the United States

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of Argatroban Injection in 0.9% sodium chloride, 250 mg/250 mL for intravenous infusion only, in the United St...

Matching PubMed Articles

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

There is an increasing prevalence of Alzheimer's disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the c...

Numerical simulation on the opto-electro-kinetic patterning for rapid concentration of particles in a microchannel.

This paper presents a mathematical model for laser-induced rapid electro-kinetic patterning (REP) to elucidate the mechanism for concentrating particles in a microchannel non-destructively and non-inv...

Crystal structure of 1-(2-chloro-acet-yl)-3,3-dimethyl-2,6-di-p-tolyl-piperidin-4-one.

In the title compound, C23H26ClNO2, the piperidin-4-one ring adopts a distorted boat conformation. The two p-tolyl rings are nearly normal to each other, making a dihedral angle of 83.33 (10)°. The...

Carbohydrate mouth rinse and caffeine improves high-intensity interval running capacity when carbohydrate restricted.

We tested the hypothesis that carbohydrate mouth rinsing, alone or in combination with caffeine, augments high-intensity interval (HIT) running capacity undertaken in a carbohydrate-restricted state. ...

Crystal structure of (3S)-3-acet-oxy-17-(pyridin-3-yl)androsta-5,16-diene.

In the title compound, C26H33NO2 [systematic name: (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodeca-hydro-1H-cyclo-penta-[a]phenanthren-3-yl acetate], the s...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement